MASLD-The New Fatty Liver Disease
Learning Objectives
By the end of this course, the learners should be able to:
- Understand the reason and definition of SLD and MASLD from old nomenclature
- How to effectively screen and work up MASLD
- Review management and treatment in MASLD
Intended Audience:
This online course is designed for pediatricians, family physicians, endocrinologists and gastroentrologists.
Abstract:
This online course provides an in-depth overview of metabolic dysfunction–associated steatotic liver disease (MASLD), the most common pediatric liver disease with rising global prevalence. Formerly referred to as nonalcoholic fatty liver disease (NAFLD), the new nomenclature reflects advances in understanding pathophysiology and reduces stigma associated with outdated terminology. The course reviews epidemiology, screening and diagnostic strategies, and highlights the role of noninvasive technologies such as MRI elastography and FibroScan in monitoring disease progression. Management approaches are discussed with emphasis on lifestyle interventions, evidence for vitamin E in pediatric MASH, and emerging therapies including GLP-1 agonists and resmetirom. Through a multidisciplinary lens, the course underscores the importance of early recognition, individualized risk assessment, and long-term follow-up to improve outcomes for children and adolescents with MASLD.
Assessment and Earning CME Credit:
This course in English is not CME-accredited. However, it provides valuable educational content that can enhance your knowledge and skills in the subject matter. To receive CME credit for this course in Armenia, you must take the course in Armenian and complete the post-course quiz. You have three chances to achieve a passing score of 70%. Once you pass the quiz, we will send your information to the Armenian Ministry of Health for credits.
Dr. Tania Mitsinokos
Tania Mitsinikos, MD, is the director of the Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Clinic and Associate Director of the Liver Transplant Hepatology Fellowship at Children's Hospital Los Angeles. She is also a Clinical Assistant Professor of Pediatrics at the Keck School of Medicine of USC. Dr. Mitsinikos' clinical interests focus on pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), pediatric hepatology, and pediatric liver transplant. She completed her medical education at the University of Southern California, Keck School of Medicine, followed by an internship and residency in general pediatrics at Children's Hospital Los Angeles. Dr. Mitsinikos then pursued a fellowship in gastroenterology and transplant hepatology at the same institution. She is board-certified in pediatrics, pediatric gastroenterology, and pediatric transplant hepatology. Dr. Mitsinikos is a member of the American Academy of Pediatrics, the North American Society of Pediatric Gastroenterology, Hepatology, & Nutrition, and the American Association for the Study of Liver Diseases.
